openPR Logo
Press release

Bullous Pemphigoid Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

03-16-2018 09:05 AM CET | Health & Medicine

Press release from: P&S Market Research

Bullous pemphigoid is a chronic autoimmune skin disorder that cause generalized, pruritic, bullous lesions in elderly patients. Bullous pemphigoid occurs more often in patients aged 60 years and above, but can also occur in children. IgG autoantibodies bind to certain hemidesmosomal antigens (BPAg1, BPAg2), resulting in the activation of complement system to form a sub epidermal blister.

Read market report summary: http://bit.ly/2plGsJk

The exact cause of bullous pemphigoid is unknown. However, some of the risk factors that may trigger the disease include drugs (including furosemide, spironolactone, sulfasalazine, penicillin, penicillamine, etanercept, and antipsychotics), physical triggers (including trauma, radiation therapy for breast cancer, UV radiation, and anthralin), skin disorders (including psoriasis, lichen planus, and some infections), diabetes mellitus, rheumatoid arthritis, ulcerative colitis, and genetic and environmental factors may also play a role. Diagnosis of bullous pemphigoid occurs by skin biopsy and immunofluorescence testing of skin and serum.

Request market report sample : http://bit.ly/2GzsSdx

The aim of bullous pemphigoid treatment is to stop new blisters forming and heal the blisters that are already there. Topical and systemic corticosteroids are used initially. The drug candidates in the pipeline of bullous pemphigoid include, but are not limited to, Ligelizumab, Bertilimumab and NPB-01.

Some of the companies having drugs in the bullous pemphigoid pipeline include iCo Therapeutics Inc., Immungenetics AG, and TxCell SA.

Access market report summary : https://www.psmarketresearch.com/market-analysis/bullous-pemphigoid-therapeutics-pipeline-analysis

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:

P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-Free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bullous Pemphigoid Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments here

News-ID: 981277 • Views:

More Releases from P&S Market Research

Smart Cities Market Size, Revenue, Technology, Competitive Analysis, Growth Drivers and Opportunities by 2023
Smart Cities Market Size, Revenue, Technology, Competitive Analysis, Growth Driv …
The global smart cities market is growing at a CAGR above 20% during 2018 - 2023 and will reach $2578.0 billion by 2023. Due to significant growth in automation technologies such as internet of things (IoT) and adoption of cloud based technologies, the global smart cities market is gaining huge traction. In addition, effective city asset management for public welfare, substantial operational cost savings, and automated public data generation applications
Global Sports Food Market Expected to Witness 9.2% CAGR During 2016 – 2022
Global Sports Food Market Expected to Witness 9.2% CAGR During 2016 – 2022
The global sports food market is expected to grow at a CAGR of 9.2% in terms of value during 2016 - 2022. Among the various types, the energy bars segment accounted for the largest share (71.5%) in the global sports food market in 2015. Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/sports-food-market/report-sample The manufacturers are trying to bring about products with the best blend of taste and healthy ingredients. They have started to
Sports Nutrition Market by Type, Distribution Channel, Region, Growth and Demand Forecast to 2022
Sports Nutrition Market by Type, Distribution Channel, Region, Growth and Demand …
The global sports nutrition market is expected to grow at a CAGR of 8.4% in terms of value during 2016 - 2022. Among the various types, the sports drinks segment accounted for largest share (61.4%) in the global sports nutrition market in 2015. Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/sports-nutrition-market/report-sample The increasing health concerns, such as obesity and awareness of physical appearances among all consumers groups is driving the demand for sports
Orthopedic Trauma Devices Market Supply Chain Trends Mapping the Latest Technological Advancements
Orthopedic Trauma Devices Market Supply Chain Trends Mapping the Latest Technolo …
The global orthopedic trauma devices market is growing due to the increasing frequency of fractures, along with the growth of aging population. The advantageous features posed by orthopedic trauma devices, such as internal and external fixators to set a fracture, and in repositioning of bone fragments into their normal alignment are also driving the growth of the market worldwide. Furthermore, the internal fixators have reduced the hospital stays, reduced the

All 5 Releases


More Releases for Bullous

Bullous Pemphigoid Market to Set Phenomenal Growth From 2025 to 2034
Introduction Bullous pemphigoid (BP) is a rare, chronic, autoimmune blistering skin disorder that primarily affects the elderly population. Characterized by large, fluid-filled blisters, intense itching, and significant discomfort, BP is associated with immune system dysfunction, where antibodies attack proteins in the skin. Although rare, its prevalence is rising due to aging populations, improved diagnostic accuracy, and increasing autoimmune disease incidence worldwide. The global bullous pemphigoid market is gaining momentum as awareness grows
Bullous Pemphigoid Market Projected to Witness Innovation in Autoimmune Therapie …
Bullous Pemphigoid Market Snapshot The Bullous Pemphigoid Market is projected to grow at a CAGR of 5.8% during the forecast period 2025-2032. Coherent Market Insights proudly presents its latest Bullous Pemphigoid Market Research Report, delivering a detailed examination of the U.S. Bullous Pemphigoid Market outlook from 2025 to 2032. This comprehensive analysis provides strategic forecasts at both national and regional levels, addressing evolving supply networks, payer-provider collaboration, and competitive strategies. As the
Bullous Pemphigoid Treatment Market Size, Share, Analysis Report and Forecast 20 …
According to the report by Expert Market Research (EMR), the global bullous pemphigoid treatment market is being driven by the rising skin disease treatment market. Aided by rising skin disease treatment market and rising accessibility of healthcare facilities, the skin disease treatment market is expected to grow at a CAGR of 3% in the forecast period of 2024-2032. Bullous pemphigoid is a chronic autoimmune skin disorder characterised by large, tense blisters
Bullous Keratopathy Treatment Market Size, Share, Industry, Forecast and Outlook …
Bullous Keratopathy Treatment Market Overview The global Bullous Keratopathy Treatment Market is anticipated to achieve a high Compound Annual Growth Rate (CAGR) during the forecast period from 2023 to 2030. Bullous Keratopathy Bullous keratopathy, also known as corneal edema, is characterized by the swelling of the cornea due to the failure of the corneal endothelium to maintain its transparent and dehydrated state. This condition often results from corneal endothelial dystrophy or trauma. The
Bullous Pemphigoid Market Size, Trends, Industry Statistics and Latest Insights …
Market Overview: The bullous pemphigoid market reached a value of US$ 208.5 Million in 2022 and expects to reach US$ 1,252.7 Million by 2033, exhibiting a growth rate (CAGR) of 17.7% during 2023-2033. The bullous pemphigoid market report offers a comprehensive analysis of the market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the
Bullous Pemphigoid Market 2020 Enhancement in Medical Sector
Bullous Pemphigoid - Pipeline Insight, 2020 The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Bullous Pemphigoid Market on the basis of stating current situation of the industry in 2020. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This